p53 family interactions and yeast: together in anticancer therapy

被引：11

作者：

Gomes, Sara ^{[1
]}

Leao, Mariana ^{[1
]}

Raimundo, Liliana ^{[1
]}

Ramos, Helena ^{[1
]}

Soares, Joana ^{[1
]}

Saraiva, Lucilia ^{[1
]}

机构：

[1] Univ Porto, Dept Ciencias Biol, Microbiol Lab, UCIBIO REQUIMTE,Fac Farm, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal

来源：

DRUG DISCOVERY TODAY | 2016年 / 21卷 / 04期

关键词：

WILD-TYPE P53; MUTANT P53; FUNCTIONAL ASSAY; TRANSCRIPTIONAL ACTIVITY; P53-MDM2; INTERACTION; MDM2; ONCOPROTEIN; 2-HYBRID SYSTEM; CANCER-THERAPY; P73; FUNCTION; IN-VITRO;

D O I：

10.1016/j.drudis.2016.02.007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The p53 family proteins are among the most appealing targets for cancer therapy. A deeper understanding of the complex interplay that these proteins establish with murine double minute (MDM)2, MDMX, and mutant p53 could reveal new exciting therapeutic opportunities in cancer treatment. Here, we summarize the most relevant advances in the biology of p53 family protein-protein interactions (PPIs), and the latest pharmacological developments achieved from targeting these interactions. We also highlight the remarkable contributions of yeast-based assays to this research. Collectively, we emphasize promising strategies, based on the inhibition of p53 family PPIs, which have expedited anticancer drug development.

引用

页码：616 / 624

页数：9

共 50 条

[1] Targeting p53 for novel anticancer therapy
Wang, Zhen
Sun, Yi
TRANSLATIONAL ONCOLOGY, 2010, 3 (01): : 1 - 12
[2] The family that eats together stays together: new p53 family transcriptional targets in autophagy
Napoli, Marco
Flores, Elsa R.
GENES & DEVELOPMENT, 2013, 27 (09) : 971 - 974
[3] P53 and induction of apoptosis as a target for anticancer therapy
Neubauer, A
Thiede, C
Huhn, D
Wittig, B
LEUKEMIA, 1996, 10 : S2 - S4
[4] P53 Family: At the Crossroads in Cancer Therapy
Alsafadi, S.
Tourpin, S.
Andre, F.
Vassal, G.
Ahomadegbe, J-C.
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (32) : 4328 - 4344
[5] Better Together: Checkpoint Therapy and p53 mRNA Nanotherapy
Genetic Engineering and Biotechnology News, 2022, 42 (04): : 14
[6] Classic and novel roles of p53:: prospects for anticancer therapy
Fuster, Jose J.
Sanz-Gonzalez, Silvia M.
Moll, Ute M.
Andres, Vicente
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (05) : 192 - 199
[7] Peptide activators of the p53 tumor suppressor for anticancer therapy
Lu, Wuyuan
BIOPOLYMERS, 2011, 96 (04) : 416 - 416
[8] The p53 family: Prospect for cancer gene therapy
Zhang, Jin
Chen, Xinbin
CANCER BIOLOGY & THERAPY, 2007, 6 (01) : 116 - 118
[9] p53 Family in Resistance to Targeted Therapy of Melanoma
Vlasic, Ignacija
Horvat, Andela
Tadijan, Ana
Slade, Neda
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
[10] Network Effect of Wt-mutant p53 Interactions and Implications on p53 Gene Therapy
Ji, Xiaona
Ma, Lijie
Huang, Qiang
Li, Zijuan
Zhao, Jing
Huang, Weixue
Ma, Buyong
Yu, Long
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1259 - 1267

← 1 2 3 4 5 →